Document Page: First | Prev | Next | All | Image | This Release | Search

Subject: DESERT SHIELD MEDICAL ISSUES REVIEW AND AD HOC WORKING GRP      

Unit: OTSG        

Parent Organization: HSC         

Box ID: BX003202

Folder Title: DESERT SHIELD MEDICAL ISSUES REVIEW AND AD HOC WORKING GROUP                                    

Document Number:          1

Folder SEQ  #:         31









          SUBJECT: Minutes of the Operation Desert Shield Medical Issues
          Working Group


          predeployment           and be given to recruits. For the
          present, we should rely on ISG in Saudi Arabia as long as it is
          available. COL Bancroft will check on price/availability of the
          Hepatitis A vaccine and report at the next meeting.

              d. Centoxin. COL Bancroft stated that there are presently
                   at the MEDSOM for all services. He supported the
          tri-service recommendation to use Centoxin for prophylaxis to
          all wounded personnel with abdominal, chest, burn, and head
          trauma. He stated that it would supplement and not replace any
          other treatment. USAMRDC is negotiating for an additional =


              e. Establishment of a "Manhattan Project" was discussed to
          evaluate vaccines in Saudi Arabia was discussed. Committee
          members felt that the timing for trials in theater was not right
          at present. There is too much else going on right now. If
          Operation Desert Shield becomes a prolonged operation, then
          trials may be possible.

              f. The committee also discussed the tri-ser-vice committee's
          recommendations to create a tri-service research task force and
          to provide appropriate funding to accomplish the mission.

          3. Recommendations:

              a. Research availability.. shelf life, etc. on the oral
          cholera vaccine and present to BG Blanck and TSG.

              b. Pursue Typhoid TY21a vaccine for its long term viability
          but do not pursue for use in operation Desert Shield.

              c. Research availability and cost of Hepatitis A vaccine.
          Continue to rely on ISG in Saudi Arabia. When available and
          efficacy demonstrated, use Hepatitis A for predeployment (2
          doses) and for recruits.

              d. Use centoxin for prophylaxis as recommended by
service committee.

              e. Refer recommendations of the tri-service committee
          concerning establishment of a "Manhattan Project", creation of a
          tri-service research task force, and funding for the mission to
          the Joint Technology Coordinating Group.


                                          2

Document Page: First | Prev | Next | All | Image | This Release | Search

Document 4 f:/Week-36/BX003202/DESERT SHIELD MEDICAL ISSUES REVIEW AND AD HOC WORKING GROUP/desert shield medical issues review and ad hoc w:11049609101516
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003202
Unit = OTSG
Parent Organization = HSC
Folder Title = DESERT SHIELD MEDICAL ISSUES REVIEW AND AD HOC WORKING GROUP
Folder Seq # = 31
Subject = DESERT SHIELD MEDICAL ISSUES REVIEW AND AD HOC W
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 04-NOV-1996